Jeff Dunkel

Jeff Dunkel has a diverse and extensive work experience. Currently, they serve as the Chief Executive Officer at Optain, a company that uses retinal imaging technology and AI algorithms for non-invasive patient health evaluation. Jeff has been involved in various executive roles throughout their career. Jeff was a Board Member at the Global Health Crisis Coordination Center and served on the Executive Operations Committee at the FDA-sponsored MDEpiNet, where they contributed to advancing evidence-based medicine in the field of medical devices. Jeff also worked as a Strategic Advisor at Mindset Medical, an intelligent digital health company. Prior to that, Jeff was the CEO of NuHope, an outpatient medical facility specializing in pain treatment and substance use disorder management. Jeff gained significant experience in organizational strategy as an Executive Team Member and Executive Vice President of Strategy at Titan Spine. Jeff has also held multiple roles at Johnson & Johnson and Ortho-Clinical Diagnostics, where they focused on business development, strategic partnerships, and sales. Additionally, they worked in IT and software sales at Synchronics Technologies. Overall, Jeff Dunkel's work experience reflects their expertise in healthcare, medical devices, strategy development, and sales.

Jeff Dunkel attended White Station High School, although the specific years were not provided. Following high school, they enrolled at Indiana University - Kelley School of Business in 1996 and graduated in 2001. During their time at Indiana University, Jeff pursued a degree in Marketing Management with a minor in Pre-Med. Jeff also attended Indiana University Bloomington, where they obtained a Bachelor of Science (B.S.) degree, though the field of study was not specified. In 1999, Jeff participated in an overseas studies program at the University of Woollongong, focusing on International Micro and Macro Economics.